PMID: 22382608
Question: SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
Correct Answer: no

======================= Launch the MCC process =======================
PMID: 22382608
Question: SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content**: The primary question investigates whether a SPECT study using I-123-Ioflupane (DaTSCAN) in patients with essential tremor (ET) reveals any correlation with Parkinson's disease (PD).
- **Key Information to Identify**:
  - Comparison of dopaminergic degeneration between ET and PD patients.
  - Differences in radiopharmaceutical uptake in specific brain regions.
  - Long-term clinical outcomes indicating progression from ET to PD.

**2. Evidence Evaluation**
- **Research Results**:
  - **Qualitative Analysis**: No difference in radiopharmaceutical uptake between ET patients and normal volunteers (NV), while PD patients showed reduced uptake in the putamen.
  - **Semiquantitative Analysis**: ET patients exhibited a slight but significant reduction in striatal uptake compared to NV. However, this reduction was not indicative of PD.
  - **Follow-Up**: Over the follow-up period, ET patients did not show significant clinical progression to PD, and follow-up DaTSCANs remained negative except for one patient with equivocal baseline results.
- **Strength and Reliability**:
  - The study included a reasonable sample size with control groups (NV and PD patients).
  - Both qualitative and semiquantitative analyses were employed, enhancing the robustness of findings.
- **Relevance**:
  - The evidence directly addresses the correlation between ET and PD through dopaminergic imaging, which is pertinent to the research question.

**3. Conclusion**
- The study does not support a direct link between essential tremor and Parkinson's disease based on DaTSCAN imaging. Although ET patients showed a minor degree of striatal dopaminergic degeneration, this does not establish a correlation with PD.

**4. Final Answer**
**My final choice is: "no"**
GPT selected: no

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether there is a correlation between SPECT studies using I-123-Ioflupane (DaTSCAN) in patients with essential tremor (ET) and Parkinson's disease (PD). Key points to assess:  
- Do ET patients show dopaminergic degeneration similar to PD on DaTSCAN?  
- Does the study support a link between ET and PD based on SPECT findings?  

**2. Evidence Evaluation**  
- **Qualitative Results**: The study found no difference in striatal, caudate, or putamen radiopharmaceutical uptake between ET patients and normal volunteers (NV).  
- **Semiquantitative Results**: ET patients showed a **significant reduction in striatal uptake** compared to NV, but this reduction was **less severe** than in PD patients (who had pronounced putamen reductions).  
- **Follow-up**: Most ET patients did not progress to PD, with only one showing worsening (who had an equivocal baseline scan).  
- **Conclusion of the Study**: The abstract explicitly states, *"Our results do not support the hypothesis of a link between essential tremor and Parkinson's disease,"* though a small degree of striatal dopaminergic degeneration was noted in ET patients. The cause of this degeneration remains unclear.  

**3. Conclusion**  
The study’s primary conclusion directly refutes a correlation between ET and PD based on DaTSCAN results. While ET patients showed mild striatal dopaminergic changes, these were distinct from PD’s more severe putamen reductions and did not correlate with progression to PD in most cases. Thus, the evidence does not support a link between ET and PD via DaTSCAN.  

**4. Final Answer:**  
**My final choice is: "no"**
Qwen selected: no

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether there is a correlation between essential tremor (ET) and Parkinson’s disease (PD) based on a SPECT study using I-123-Ioflupane (DaTSCAN). Key elements to evaluate include:  
- Differences in dopaminergic degeneration (via DaTSCAN uptake) between ET, PD, and normal volunteers (NV).  
- Clinical follow-up data to assess progression of ET to PD.  

**2. Evidence Evaluation**  
- **Qualitative Analysis**: No visual differences in striatal, caudate, or putamen uptake were observed between ET patients and NV, but PD patients showed reduced putamen uptake.  
- **Semiquantitative Analysis**: ET patients exhibited a small but significant reduction in striatal uptake compared to NV. However, PD patients showed pronounced reductions in putamen uptake, with asymmetry matching their clinical presentation.  
- **Follow-up**: 20 ET patients showed no progression to PD during follow-up. Repeat DaTSCAN in 10 patients remained negative except one equivocal case, which deteriorated later (possibly indicating incidental PD).  
- **Conclusion of the Study**: The authors explicitly state that their results do not support a link between ET and PD, though they note a minor dopaminergic degeneration in ET of unclear origin.  

**3. Conclusion**  
The study found no evidence of a direct correlation between ET and PD. While ET patients showed mild striatal dopaminergic degeneration, this did not align with PD-specific patterns (e.g., putamen asymmetry) or clinical progression to PD. The authors attribute the degeneration in ET to an unknown cause unrelated to PD pathology.  

**4. Final Answer**  
**My final choice is: no**
DeepSeek selected: no

Initial consensus: All models selected no